Drug Safety

The Erice Manifesto: For Global Reform of the Safety of Medicines in Patient Care
pp. 187-190(4)
Author: Adis International Limited,

Poisons Centres and the Reporting of Adverse Drug Events: The Case for Further Development
pp. 191-194(4)
Authors: Volans, Glyn N.; Karalliedde, Lakshman; Wiseman, Heather M.

Psychiatric Adverse Reactions with Statins, Fibrates and Ezetimibe: Implications for the Use of Lipid-Lowering Agents
pp. 195-201(7)
Authors: Tatley, Michael; Savage, Ruth

Safety of Agents Used to Prevent Mother-to-Child Transmission of HIV: Is There Any Cause for Concern?
pp. 203-213(11)
Authors: Thorne, Claire; Newell, Marie-Louise

Drug-Induced Endocrine and Metabolic Disorders
pp. 215-245(31)
Authors: C.W., Ronald; Kong, Alice P.S.; Chan, Norman; Tong, Peter C.Y.; Chan, Juliana C.N.

Evaluating the Postmarketing Experience of Risperidone Use During Pregnancy: Pregnancy and Neonatal Outcomes
pp. 247-264(18)
Authors: Coppola, Danielle; Russo, Leo J.; Kwarta, Robert F.; Varughese, Ruana; Schmider, Juergen

Survey of Forged Prescriptions to Investigate Risk of Psychoactive Medications Abuse in France: Results of OSIAP Survey
pp. 265-276(12)
Authors: Boeuf, Olivia; Lapeyre-Mestre, Maryse